Status:

RECRUITING

Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

Lead Sponsor:

Region Stockholm

Collaborating Sponsors:

Rigshospitalet, Denmark

Conditions:

Cognitive Impairment

Cognitive Decline

Eligibility:

All Genders

5+ years

Phase:

PHASE2

Brief Summary

Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain r...

Detailed Description

Late-appearing cognitive side effects after brain radiotherapy is a potential disabling condition in pediatric brain tumor survivors. It can have profound negative effects on education, career options...

Eligibility Criteria

Inclusion

  • Age \>5 years.
  • Age \<18 years at time of radiotherapy.
  • Has received cranial/craniospinal radiation treatment of brain tumor within the last 7 years.
  • Adequate contraceptive method to prevent pregnancy\* during the entire lithium treatment period and six months thereafter.
  • Negative pregnancy test\* at screening, at start of study treatment, and monthly thereafter.
  • Written informed consent from patient and/or caregiver.

Exclusion

  • Allergy/hypersensitivity to lithium or any of the excipients
  • Renal failure (Cystatin C derived Glomerular Filtration Rate \< 60).
  • Cardiac failure or heart disease, including Brugada syndrome (or family history thereof).
  • Uncontrolled hypothyroidism.
  • Pregnancy or breast feeding.
  • Severe fluid or electrolyte imbalance.
  • Karnofsky-Lansky score \< 60.
  • Other condition deemed incompatible with inclusion in this study (estimated 2 year survival prognosis less than 25 %, expected poor protocol compliance, inability to swallow tablets, language difficulties).
  • Inclusion in other study protocol precluding inclusion in this study.

Key Trial Info

Start Date :

February 16 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2033

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT06051240

Start Date

February 16 2024

End Date

August 31 2033

Last Update

April 12 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Karolinska Universitetssjukhuset

Solna, Stockholm County, Sweden, 171 64

2

HOPE

Stockholm, Sweden, 17176